サマリー

迅速がん検査は、がんの迅速な診断に使用される検査の一種です。
市場分析とインサイト迅速がん検査の世界市場
COVID-19のパンデミックにより、世界のRapid Cancer Testsの市場規模は2022年には100万米ドルと推定され、検討期間中のCAGRは%で2028年には再調整されて100万米ドルになると予測されています。この健康危機による経済的変化を十分に考慮した上で、血液検査は2021年にRapid Cancer Testsの世界市場の%を占めていましたが、COVID-19後の期間に改訂された%のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、病院のセグメントは、この予測期間中、年率％で変化しています。
中国のRapid Cancer Testsの市場規模は2021年に100万米ドル、米国と欧州のRapid Cancer Testsはそれぞれ100万米ドルと100万米ドルとなっています。2021年の米国の割合は%で、中国と欧州はそれぞれ%と%で、中国の割合は2028年に%に達し、分析期間中のCAGRは%になると予測されます。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の迅速がん検査市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
Rapid Cancer Testsの世界的な主要メーカーには、Abingdon Health社、Abbott社、Alfa Scientific Designs社、NanoEntek社、Biomerica社、Biosynex社、IDL Biotech社、Exact Sciences社、Firstep Bioresearch社などがあります。2021年には、世界の上位5社の売上高シェアは約%となっています。
世界の迅速癌検査の範囲とセグメント
迅速ながん検査市場は、タイプ別、アプリケーション別に分類されます。世界のRapid Cancer Tests市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
タイプ別セグメント
血液検査
尿検査
その他
アプリケーション別
病院
クリニック
その他
会社別
アビンドン・ヘルス
アボット
アルファサイエンティフィックデザインズ
ナノエンテック
ビオメリカ
バイオサイネックス
IDLバイオテック
エグザクト・サイエンス
ファーストップ・バイオリサーチ
ホログラム
ライフアッセイ
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Rapid Cancer Tests Product Introduction
1.2 Market by Type
1.2.1 Global Rapid Cancer Tests Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Others
1.3 Market by Application
1.3.1 Global Rapid Cancer Tests Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rapid Cancer Tests Sales Estimates and Forecasts 2017-2028
2.2 Global Rapid Cancer Tests Revenue Estimates and Forecasts 2017-2028
2.3 Global Rapid Cancer Tests Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Rapid Cancer Tests Sales by Region
2.4.1 Global Rapid Cancer Tests Sales by Region (2017-2022)
2.4.2 Global Sales Rapid Cancer Tests by Region (2023-2028)
2.5 Global Rapid Cancer Tests Revenue by Region
2.5.1 Global Rapid Cancer Tests Revenue by Region (2017-2022)
2.5.2 Global Rapid Cancer Tests Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rapid Cancer Tests Sales by Manufacturers
3.1.1 Global Top Rapid Cancer Tests Manufacturers by Sales (2017-2022)
3.1.2 Global Rapid Cancer Tests Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rapid Cancer Tests in 2021
3.2 Global Rapid Cancer Tests Revenue by Manufacturers
3.2.1 Global Rapid Cancer Tests Revenue by Manufacturers (2017-2022)
3.2.2 Global Rapid Cancer Tests Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Rapid Cancer Tests Revenue in 2021
3.3 Global Rapid Cancer Tests Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rapid Cancer Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rapid Cancer Tests Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rapid Cancer Tests Sales by Type
4.1.1 Global Rapid Cancer Tests Historical Sales by Type (2017-2022)
4.1.2 Global Rapid Cancer Tests Forecasted Sales by Type (2023-2028)
4.1.3 Global Rapid Cancer Tests Sales Market Share by Type (2017-2028)
4.2 Global Rapid Cancer Tests Revenue by Type
4.2.1 Global Rapid Cancer Tests Historical Revenue by Type (2017-2022)
4.2.2 Global Rapid Cancer Tests Forecasted Revenue by Type (2023-2028)
4.2.3 Global Rapid Cancer Tests Revenue Market Share by Type (2017-2028)
4.3 Global Rapid Cancer Tests Price by Type
4.3.1 Global Rapid Cancer Tests Price by Type (2017-2022)
4.3.2 Global Rapid Cancer Tests Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Rapid Cancer Tests Sales by Application
5.1.1 Global Rapid Cancer Tests Historical Sales by Application (2017-2022)
5.1.2 Global Rapid Cancer Tests Forecasted Sales by Application (2023-2028)
5.1.3 Global Rapid Cancer Tests Sales Market Share by Application (2017-2028)
5.2 Global Rapid Cancer Tests Revenue by Application
5.2.1 Global Rapid Cancer Tests Historical Revenue by Application (2017-2022)
5.2.2 Global Rapid Cancer Tests Forecasted Revenue by Application (2023-2028)
5.2.3 Global Rapid Cancer Tests Revenue Market Share by Application (2017-2028)
5.3 Global Rapid Cancer Tests Price by Application
5.3.1 Global Rapid Cancer Tests Price by Application (2017-2022)
5.3.2 Global Rapid Cancer Tests Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rapid Cancer Tests Market Size by Type
6.1.1 North America Rapid Cancer Tests Sales by Type (2017-2028)
6.1.2 North America Rapid Cancer Tests Revenue by Type (2017-2028)
6.2 North America Rapid Cancer Tests Market Size by Application
6.2.1 North America Rapid Cancer Tests Sales by Application (2017-2028)
6.2.2 North America Rapid Cancer Tests Revenue by Application (2017-2028)
6.3 North America Rapid Cancer Tests Market Size by Country
6.3.1 North America Rapid Cancer Tests Sales by Country (2017-2028)
6.3.2 North America Rapid Cancer Tests Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Rapid Cancer Tests Market Size by Type
7.1.1 Europe Rapid Cancer Tests Sales by Type (2017-2028)
7.1.2 Europe Rapid Cancer Tests Revenue by Type (2017-2028)
7.2 Europe Rapid Cancer Tests Market Size by Application
7.2.1 Europe Rapid Cancer Tests Sales by Application (2017-2028)
7.2.2 Europe Rapid Cancer Tests Revenue by Application (2017-2028)
7.3 Europe Rapid Cancer Tests Market Size by Country
7.3.1 Europe Rapid Cancer Tests Sales by Country (2017-2028)
7.3.2 Europe Rapid Cancer Tests Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rapid Cancer Tests Market Size by Type
8.1.1 Asia Pacific Rapid Cancer Tests Sales by Type (2017-2028)
8.1.2 Asia Pacific Rapid Cancer Tests Revenue by Type (2017-2028)
8.2 Asia Pacific Rapid Cancer Tests Market Size by Application
8.2.1 Asia Pacific Rapid Cancer Tests Sales by Application (2017-2028)
8.2.2 Asia Pacific Rapid Cancer Tests Revenue by Application (2017-2028)
8.3 Asia Pacific Rapid Cancer Tests Market Size by Region
8.3.1 Asia Pacific Rapid Cancer Tests Sales by Region (2017-2028)
8.3.2 Asia Pacific Rapid Cancer Tests Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Rapid Cancer Tests Market Size by Type
9.1.1 Latin America Rapid Cancer Tests Sales by Type (2017-2028)
9.1.2 Latin America Rapid Cancer Tests Revenue by Type (2017-2028)
9.2 Latin America Rapid Cancer Tests Market Size by Application
9.2.1 Latin America Rapid Cancer Tests Sales by Application (2017-2028)
9.2.2 Latin America Rapid Cancer Tests Revenue by Application (2017-2028)
9.3 Latin America Rapid Cancer Tests Market Size by Country
9.3.1 Latin America Rapid Cancer Tests Sales by Country (2017-2028)
9.3.2 Latin America Rapid Cancer Tests Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rapid Cancer Tests Market Size by Type
10.1.1 Middle East and Africa Rapid Cancer Tests Sales by Type (2017-2028)
10.1.2 Middle East and Africa Rapid Cancer Tests Revenue by Type (2017-2028)
10.2 Middle East and Africa Rapid Cancer Tests Market Size by Application
10.2.1 Middle East and Africa Rapid Cancer Tests Sales by Application (2017-2028)
10.2.2 Middle East and Africa Rapid Cancer Tests Revenue by Application (2017-2028)
10.3 Middle East and Africa Rapid Cancer Tests Market Size by Country
10.3.1 Middle East and Africa Rapid Cancer Tests Sales by Country (2017-2028)
10.3.2 Middle East and Africa Rapid Cancer Tests Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abingdon Health
11.1.1 Abingdon Health Corporation Information
11.1.2 Abingdon Health Overview
11.1.3 Abingdon Health Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abingdon Health Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abingdon Health Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Alfa Scientific Designs
11.3.1 Alfa Scientific Designs Corporation Information
11.3.2 Alfa Scientific Designs Overview
11.3.3 Alfa Scientific Designs Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Alfa Scientific Designs Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Alfa Scientific Designs Recent Developments
11.4 NanoEntek
11.4.1 NanoEntek Corporation Information
11.4.2 NanoEntek Overview
11.4.3 NanoEntek Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 NanoEntek Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 NanoEntek Recent Developments
11.5 Biomerica
11.5.1 Biomerica Corporation Information
11.5.2 Biomerica Overview
11.5.3 Biomerica Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biomerica Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biomerica Recent Developments
11.6 Biosynex
11.6.1 Biosynex Corporation Information
11.6.2 Biosynex Overview
11.6.3 Biosynex Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Biosynex Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biosynex Recent Developments
11.7 IDL Biotech
11.7.1 IDL Biotech Corporation Information
11.7.2 IDL Biotech Overview
11.7.3 IDL Biotech Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 IDL Biotech Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 IDL Biotech Recent Developments
11.8 Exact Sciences
11.8.1 Exact Sciences Corporation Information
11.8.2 Exact Sciences Overview
11.8.3 Exact Sciences Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Exact Sciences Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Exact Sciences Recent Developments
11.9 Firstep Bioresearch
11.9.1 Firstep Bioresearch Corporation Information
11.9.2 Firstep Bioresearch Overview
11.9.3 Firstep Bioresearch Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Firstep Bioresearch Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Firstep Bioresearch Recent Developments
11.10 Hologic
11.10.1 Hologic Corporation Information
11.10.2 Hologic Overview
11.10.3 Hologic Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hologic Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hologic Recent Developments
11.11 LifeAssays
11.11.1 LifeAssays Corporation Information
11.11.2 LifeAssays Overview
11.11.3 LifeAssays Rapid Cancer Tests Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 LifeAssays Rapid Cancer Tests Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 LifeAssays Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rapid Cancer Tests Industry Chain Analysis
12.2 Rapid Cancer Tests Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rapid Cancer Tests Production Mode & Process
12.4 Rapid Cancer Tests Sales and Marketing
12.4.1 Rapid Cancer Tests Sales Channels
12.4.2 Rapid Cancer Tests Distributors
12.5 Rapid Cancer Tests Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rapid Cancer Tests Industry Trends
13.2 Rapid Cancer Tests Market Drivers
13.3 Rapid Cancer Tests Market Challenges
13.4 Rapid Cancer Tests Market Restraints
14 Key Findings in The Global Rapid Cancer Tests Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer